Milton H Werner

2PUBLICATIONS
9CO-AUTHORS
Molecular targetsToxicology (incl. clinical toxicology)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (2)

|Feb 20, 2026
The 201 Trial: a placebo-controlled randomized phase 2 study of safety and tolerance of the c-Abl kinase inhibitor risvodetinib in untreated Parkinson's disease.

M H Werner, A McGarry, C Meyer

|Nov 24, 2021
Parkinson's Disease Modification Through Abl Kinase Inhibition: An Opportunity.

Milton H Werner, C Warren Olanow

Pageof 1

Frequent Collaborators

1 joint publications

A McGarry

1 joint publications

K Kieburtz

1 joint publications

R A Hauser

1 joint publications

K Shannon